Printer Friendly

Research and Markets: Coronary Artery Disease Partnering 2007-2012.

DUBLIN -- Research and Markets ( has announced the addition of the "Coronary Artery Disease Partnering 2007-2012" company profile to their offering.

The Coronary Artery Disease Partnering 2007-2012 provides understanding and access to the coronary artery disease partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of coronary artery disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors coronary artery disease technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partners negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered contract documents provide this insight where press releases do not.

This data driven report contains over 25 links to online copies of actual coronary artery disease deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partners flexibility on a wide range of important issues, many of which will have a significant impact on each partys ability to derive value from the deal.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of coronary artery disease technologies and products.

This Data Driven Report Includes:

- Trends in coronary artery disease dealmaking in the biopharma industry since 2007

- Access to summary headline, upfront, milestone and royalty data

- Access to over 25 coronary artery disease contract documents

- The leading coronary artery disease deals by value since 2007

The available deals are listed by:

- Headline value

- Upfront payment value

- Royalty rate value

- Company A-Z

- Industry sector

- Stage of development at signing

- Deal component type

- Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in coronary artery disease partnering

Chapter 3 - Leading coronary artery disease deals

Chapter 4 - Dealmaking directory

Chapter 5 - Partnering resource center

For more information visit
COPYRIGHT 2012 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 23, 2012
Previous Article:Research and Markets: Expandable Polystyrene (EPS) Industry Outlook in Argentina to 2016 - Market Size, Company Share, Price Trends, Capacity...
Next Article:UAE Exchange partners again with UNICEF this Ramadan to spread smiles among underprivileged children.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters